Global manufacturing footprint Biofarma Group operates multiple production sites across Italy, France, the USA and China, highlighting a scalable, globally distributed manufacturing capability that can support multinational nutraceutical, medical device and cosmetics orders for potential clients seeking regionalized supply and nearshoring options.

Full-service outsourcing The company offers end-to-end solutions from ideation to finished product, including development, packaging, clinical-backed product lines, and out-licensing of medical devices with dossiers, enabling potential buyers to outsource R&D, regulatory, and manufacturing through a single partner.

Diversified product catalog With a broad portfolio spanning food supplements, probiotic-based drugs, cosmetics and medical devices, Biofarma provides cross-category opportunities for customers looking to expand or consolidate wellness, pharma and beauty care product lines.

Strategic acquisitions momentum Recent acquisitions such as Nutraskills and US Pharmalab Inc. signal a growth trajectory, expanded US footprint, and enhanced nutraceutical capabilities, presenting cross-sell and integration opportunities for distributors and manufacturers seeking scale and geographic diversification.

Strategic collaborations potential Historical involvement in vaccine-related milestones and a high-value partnership profile (including private equity ownership) suggests potential for co-development, contract manufacturing, and licensing deals with pharma, biotech and consumer health brands seeking innovative platforms and global reach.